You searched for Máy ti - Page 15 of 24

December 3, 2020

C-Path Selects Aridhia to Support Rare Disease Cures Accelerator-Data and Analytics Platform

TUCSON, Ariz., December 3, 2020 — The Critical Path Institute (C-Path) today announced it has selected Aridhia to support

C-Path, NORD, FDA and more come together to showcase the importance of data sharing in rare disease drug development

Safety biomarkers aim to provide an additional tool for detecting acute drug-induced skeletal muscle injury in phase 1 clinical tr

Biomarker aims to provide an additional tool for detecting the onset of hepatic injury in clinical trials involving patients with

Clinicians to report novel uses of existing drugs through FDA-NCATS CURE ID Mobile App. TUCSON, Ariz., June 23, 2020 — As millio

June 20, 2020

Biomarker aims to streamline the development of novel therapies intended to improve long-term outcomes for kidney transplan

May 6, 2020

TUCSON, Ariz., and OLDWICK, N.J. May 13, 2020 — The Critical Path Institute (C-Path) and Provention Bio, Inc. (Nas

June 5, 2020

Join C-Path, the National Organization for Rare Disorders and the FDA for a free 1-hour webinar on the Rare Disease Cures Accelera

May 7, 2021

The Patient-Reported Outcome Consortium’s Rare Disease Subcommittee is pleased to invite you to view the complimentary virtual w